Data released Wednesday shows that per 10,000 people, the rate of infections among persons who have taken either the first or second dose of Bharat Biotech's Covaxin or Serum Institute's Covishield is extremely low
Check out our Festive offers upto Rs.1000/- off website prices on subscriptions + Gift card worth Rs 500/- from Eatbetterco.com. Click here to know more.
Get the latest stories, videos, and podcasts from Forbes India directly in your inbox every Saturday
Post Your Comment
Thank you for your comment, we value your opinion and the time you took to write to us!